QRG Capital Management Inc. Invests $217,000 in Waters Co. (NYSE:WAT)

QRG Capital Management Inc. bought a new stake in Waters Co. (NYSE:WATFree Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 658 shares of the medical instruments supplier’s stock, valued at approximately $217,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in WAT. Invesco Ltd. grew its holdings in shares of Waters by 3.0% in the 3rd quarter. Invesco Ltd. now owns 1,092,459 shares of the medical instruments supplier’s stock valued at $299,563,000 after acquiring an additional 32,059 shares in the last quarter. Nordea Investment Management AB increased its position in shares of Waters by 129.9% during the 4th quarter. Nordea Investment Management AB now owns 973,537 shares of the medical instruments supplier’s stock worth $322,017,000 after purchasing an additional 550,112 shares during the last quarter. American Century Companies Inc. raised its stake in shares of Waters by 34.3% during the 3rd quarter. American Century Companies Inc. now owns 832,895 shares of the medical instruments supplier’s stock worth $228,388,000 after purchasing an additional 212,754 shares in the last quarter. Boston Trust Walden Corp boosted its holdings in shares of Waters by 1.8% in the 4th quarter. Boston Trust Walden Corp now owns 582,048 shares of the medical instruments supplier’s stock valued at $191,628,000 after buying an additional 10,550 shares during the last quarter. Finally, London Co. of Virginia acquired a new stake in shares of Waters in the 3rd quarter valued at approximately $158,723,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Stock Down 0.7 %

WAT stock opened at $351.65 on Wednesday. The business’s fifty day moving average price is $333.61 and its two-hundred day moving average price is $318.11. The stock has a market capitalization of $20.86 billion, a price-to-earnings ratio of 34.51, a PEG ratio of 5.63 and a beta of 0.98. Waters Co. has a fifty-two week low of $231.90 and a fifty-two week high of $367.21. The company has a debt-to-equity ratio of 1.60, a current ratio of 1.94 and a quick ratio of 1.30.

Waters (NYSE:WATGet Free Report) last issued its quarterly earnings data on Tuesday, May 7th. The medical instruments supplier reported $2.21 earnings per share for the quarter, topping the consensus estimate of $2.10 by $0.11. Waters had a net margin of 20.75% and a return on equity of 66.59%. The business had revenue of $636.80 million during the quarter, compared to analysts’ expectations of $635.57 million. During the same quarter in the previous year, the company earned $2.49 EPS. The business’s revenue was down 7.0% on a year-over-year basis. On average, equities analysts anticipate that Waters Co. will post 11.86 earnings per share for the current year.

Wall Street Analyst Weigh In

WAT has been the topic of several analyst reports. Barclays dropped their price target on shares of Waters from $300.00 to $295.00 and set an “underweight” rating on the stock in a research report on Wednesday, May 8th. Evercore ISI raised their target price on shares of Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a research note on Thursday, April 4th. Stifel Nicolaus boosted their price target on Waters from $330.00 to $332.00 and gave the stock a “hold” rating in a research report on Wednesday, May 8th. Robert W. Baird cut their price objective on Waters from $319.00 to $312.00 and set a “neutral” rating for the company in a research report on Wednesday, May 8th. Finally, TD Cowen boosted their target price on Waters from $350.00 to $358.00 and gave the stock a “hold” rating in a report on Wednesday, May 8th. One research analyst has rated the stock with a sell rating and ten have issued a hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $305.78.

Get Our Latest Analysis on Waters

Insider Activity at Waters

In other Waters news, Director Christopher A. Kuebler sold 4,000 shares of the firm’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $361.64, for a total transaction of $1,446,560.00. Following the transaction, the director now owns 14,716 shares in the company, valued at approximately $5,321,894.24. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, Director Linda Baddour sold 500 shares of the stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total value of $177,770.00. Following the completion of the transaction, the director now owns 2,250 shares of the company’s stock, valued at $799,965. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Christopher A. Kuebler sold 4,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $361.64, for a total transaction of $1,446,560.00. Following the completion of the sale, the director now owns 14,716 shares in the company, valued at approximately $5,321,894.24. The disclosure for this sale can be found here. 0.82% of the stock is currently owned by corporate insiders.

About Waters

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Stories

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.